No connection

Search Results

ASRT vs FORA

ASRT
Assertio Holdings, Inc.
BEARISH
Price
$11.66
Market Cap
$74.8M
Sector
Healthcare
AI Confidence
85%
FORA
Forian Inc.
BEARISH
Price
$2.14
Market Cap
$66.9M
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
ASRT
--
FORA
--
Forward P/E
ASRT
7.77
FORA
23.78
P/B Ratio
ASRT
0.71
FORA
2.23
P/S Ratio
ASRT
0.54
FORA
2.21
EV/EBITDA
ASRT
1.98
FORA
-9.93

Profitability

Gross Margin
ASRT
65.47%
FORA
53.21%
Operating Margin
ASRT
28.72%
FORA
-24.44%
Profit Margin
ASRT
-21.06%
FORA
-9.5%
ROE
ASRT
-24.48%
FORA
-9.61%
ROA
ASRT
-4.17%
FORA
-5.15%

Growth

Revenue Growth
ASRT
69.4%
FORA
37.0%
Earnings Growth
ASRT
--
FORA
--

Financial Health

Debt/Equity
ASRT
0.38
FORA
0.0
Current Ratio
ASRT
1.58
FORA
2.96
Quick Ratio
ASRT
1.41
FORA
2.78

Dividends

Dividend Yield
ASRT
--
FORA
--
Payout Ratio
ASRT
0.0%
FORA
0.0%

AI Verdict

ASRT BEARISH

ASRT's Piotroski F-Score of 2/9 indicates severe financial distress, with weak profitability, negative ROE and ROA, and inconsistent earnings performance. The absence of an Altman Z-Score raises concern about potential bankruptcy risk, especially given negative earnings and high revenue volatility. Despite strong revenue growth (69.4% YoY) and a low price-to-sales ratio (0.54), the company trades at a significant discount due to deep operational losses and poor capital efficiency. Insider selling activity and a 5-year price decline of 80.4% further undermine confidence. The stock's current valuation appears unsustainable without a clear path to sustained profitability.

Strengths
69.4% YoY revenue growth indicates strong top-line momentum
High gross margin of 65.47% suggests strong pricing power or cost control
Low price-to-sales ratio (0.54) implies potential undervaluation on a revenue basis
Risks
Piotroski F-Score of 2/9 signals extreme financial weakness and distress
Negative ROE (-24.48%) and ROA (-4.17%) indicate poor return on capital
Persistent net losses (profit margin -21.06%) and inconsistent earnings surprises
FORA BEARISH

FORA exhibits severe fundamental weakness as evidenced by a Piotroski F-Score of 2/9, indicating poor operational efficiency and financial health. While the company maintains a debt-free balance sheet and strong liquidity (Current Ratio 2.96), it is struggling to translate 37% revenue growth into bottom-line profitability. The technical trend is completely bearish (0/100) and the 5-year price performance is devastating (-82.8%), suggesting a long-term loss of investor confidence. Despite a healthy gross margin of 53.21%, the negative operating margins and lack of deterministic value markers make this a high-risk speculative play.

Strengths
Zero debt (Debt/Equity: 0.00)
Strong short-term liquidity (Current Ratio: 2.96)
Robust revenue growth (37% YoY)
Risks
Critically low Piotroski F-Score (2/9) indicating fundamental deterioration
Negative operating margins (-24.44%)
Severe long-term price depreciation (-82.8% over 5 years)

Compare Another Pair

ASRT vs FORA: Head-to-Head Comparison

This page compares Assertio Holdings, Inc. (ASRT) and Forian Inc. (FORA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile